Credit Agricole’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Credit Agricole’s Portfolio SRNE Stock Details SRNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-7,000	Closed	-$2.52K	–	734
2023 Q1	$2.52K	Hold	7,000	–	–	﹤0.01%	624
2022 Q4	$6.2K	Hold	7,000	–	–	﹤0.01%	641
2022 Q3	$11K	Hold	7,000	–	–	﹤0.01%	604
2022 Q2	$14K	Hold	7,000	–	–	﹤0.01%	591
2022 Q1	$16K	Hold	7,000	–	–	﹤0.01%	612
2021 Q4	$33K	Hold	7,000	–	–	﹤0.01%	576
2021 Q3	$53K	Hold	7,000	–	–	﹤0.01%	502
2021 Q2	$68K	Buy	7,000 +2,000	+40%	+$15.9K	﹤0.01%	464
2021 Q1	$41K	Buy	+5,000	New	+$52.8K	﹤0.01%	470

Other funds holding SRNE

SlateStone Wealth Jupiter, Florida $1.31B AUM 26.51% 1-Year Est. Return

KLCM Advisors Milwaukee, Wisconsin $1.27B AUM 31.14% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

AlphaMark Advisors Ft. Wright, Kentucky $231M AUM 19.98% 1-Year Est. Return

OAJ

Ogorek Anthony Joseph Williamsville, New York $403M AUM 22.57% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

TCOV

Trust Company of Vermont Brattleboro, Vermont $2.68B AUM

CFGS

Concourse Financial Group Securities Birmingham, Alabama $1.77B AUM 17.37% 1-Year Est. Return

Credit Agricole's SRNE Position: Q2 2023 in Review

Credit Agricole sold out of Sorrento Therapeutics, Inc. (SRNE) in Q2 2023, closing a stake of 7,000 shares — an estimated $2.52K sold.

Credit Agricole first reported a position in SRNE in Q1 2021 and held it in 9 quarters. The position peaked at $68K in Q2 2021. 9 funds tracked by Wall St. Rank hold SRNE as of Q2 2023.

Credit Agricole reported no remaining Sorrento Therapeutics, Inc. position as of Q2 2023 after selling out during the quarter.
Credit Agricole sold 7,000 Sorrento Therapeutics, Inc. shares in Q2 2023, an estimated $2.52K.
Credit Agricole first reported a position in Sorrento Therapeutics, Inc. in Q1 2021 and held it in 9 quarters.
Credit Agricole's Sorrento Therapeutics, Inc. position peaked at $68K in Q2 2021.
9 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q2 2023.

Based on Credit Agricole's 13F filing for Q2 2023, filed 31 Jul 2023.